Investors Grab NKTR Even Cheaper Than Its Secondary Stock Offering
October 20, 2016 at 09:58 AM EDT
Looking back to 2 days ago, Nektar Therapeutics (NKTR) priced a 13,000,000 share secondary stock offering at $13.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..